According to bioMรฉrieux's latest financial reports the company has C$0.64 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | C$0.67 B | 29.99% |
2023-12-31 | C$0.51 B | -35.76% |
2022-12-31 | C$0.80 B | -30.64% |
2021-12-31 | C$1.15 B | 89.99% |
2020-12-31 | C$0.61 B | 51.71% |
2019-12-31 | C$0.40 B | -10.44% |
2018-12-31 | C$0.44 B | -4.57% |
2017-12-31 | C$0.47 B | 86.49% |
2016-12-31 | C$0.25 B | 13.15% |
2015-12-31 | C$0.22 B | 32.07% |
2014-12-31 | C$0.16 B | -73.15% |
2013-12-31 | C$0.62 B | 629.18% |
2012-12-31 | C$86.28 M | 52.98% |
2011-12-31 | C$56.4 M | -40.58% |
2010-12-31 | C$94.93 M | 33.99% |
2009-12-31 | C$70.85 M | -21.06% |
2008-12-31 | C$89.75 M | 13.06% |
2007-12-31 | C$79.38 M | 52.43% |
2006-12-31 | C$52.08 M | 80.68% |
2005-12-31 | C$28.82 M |